The KC Foundation for PF,  Dr. Mark Hamblin, and his staff  hosted a virtual Patient Education Symposium.

​

The symposium was held over three Saturdays .

​

• September 11th

1.  IPF vs. PF – discussion of different types of pulmonary fibrosis; how imaging and diagnosis may influence management with  genetic tie in.  

2. Anti-fibrotic therapy and clinical trials.  

​​​

• September 25th 

1. IPF Co-morbidities (Cough, GERD, CAD, OSA).  

2. Non-pharmacologic Therapy (without medications)  (Oxygen, pulmonary rehabilitation, and other treatments).  

3. Lung Transplant.  

​

• October 2nd

1. PH-ILD – Pulmonary hypertension associated with Interstitial Lung Disease.  

2. End of Life Care (Symptom management, palliative care, hospice) . 

 

 

​